NASDAQ: AHGAkso Health Group Stock
$1.12+0.02 (+1.82%)
Updated Oct 4, 2024
AHG Price
$1.12
Fair Value Price
$2.73
Market Cap
$163.05M
52 Week Low
$0.53
52 Week High
$2.90
P/E
-5.33x
P/B
1.18x
P/S
22.66x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.41M
Earnings
-$9.46M
Gross Margin
5.1%
Operating Margin
-390.74%
Profit Margin
-391.8%
Debt to Equity
0.03
Operating Cash Flow
$1M
Beta
0.84
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AHG Overview
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.
Zen Score
–
Industry Average (39)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AHG scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AHG ($1.12) is undervalued by 58.9% relative to our estimate of its Fair Value price of $2.73 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AHG ($1.12) is significantly undervalued by 58.9% relative to our estimate of its Fair Value price of $2.73 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
AHG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more AHG due diligence checks available for Premium users.
Be the first to know about important AHG news, forecast changes, insider trades & much more!
AHG News
Valuation
AHG fair value
Fair Value of AHG stock based on Discounted Cash Flow (DCF)
Price
$1.12
Fair Value
$2.73
Undervalued by
58.90%
AHG ($1.12) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AHG ($1.12) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AHG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
AHG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-5.33x
Industry
23.92x
Market
26.83x
AHG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.18x
Industry
94.96x
AHG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AHG's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
AHG's Earnings (EBIT) of -$9.43M... subscribe to Premium to read more.
Interest Coverage Financials
AHG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$142.0M
Liabilities
$3.6M
Debt to equity
0.03
AHG's short-term assets ($142.02M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AHG's short-term assets ($142.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AHG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AHG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
AHG's operating cash flow ($1.35M)... subscribe to Premium to read more.
Debt Coverage Financials
AHG vs Medical Distribution Stocks
Akso Health Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.